Interest of an Attentional Evaluation by a Computerized Battery in the Management of Concussion in Young Rugby Players (NeuropsyCor)

The goal of this study is to test the ability of a computerized neuropsychological battery to identify attentional disorders resulting from a concussion occurring during the practice of rugby. Thirty young people with a concussion (11-25 years old) will take several neuropsychological tests. Researchers will compare their results with those of young athletes without concussion to see the effect of concussion.

Study Overview

• Status: Recruiting
• Conditions: Concussion, Brain
• Intervention / Treatment: Diagnostic test: Neuropsychological tests

Detailed Description

The objective is to carry out a complete neuropsychological assessment, detailing the attentional and executive aspects using the TAP computerized battery. In addition, various paper-and-pencil tests, standardized in French, more commonly used in the context of neuropsychological data related to concussions in athletes, will also be administered. These assess processing speed, short-term memory and auditory-verbal working memory capacity, episodic memory and selective attention. This preliminary study would make it possible to shed light on the links that may exist between performance in the various tests proposed and the characteristics inherent in the symptomatology of concussion. Furthermore, it seems relevant to compare the results of computerized tests with other paper-and-pencil tests but also with the performance of individuals who have no history of concussion with the practice of a non-contact sport.

The results of this study would make it possible in practice to have a neuropsychological assessment more specific to cerebral concussion, with a potentially reduced consultation time due to the use of more sensitive tools, and therefore, an earlier rehabilitative intervention.

• Study Type: Interventional
• Enrollment (Estimated): 90
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Lise LACLAUTRE; Phone Number: +334.73.754.963; Email: promo_interne_drci@chu-clermontferrand.fr

Study Locations

• France
  • Clermont-Ferrand, France, 63000
    • Recruiting
    • CHU de Clermont-Ferrand
    • Contact: LISE LACLAUTRE; Phone Number: +33473754963; Email: promo_interne_drci@chu-clermontferrand.fr

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 11 years to 25 years (Child, Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

• Patients :
• concussion in the context of the practice of rugby
• French or reading French without help
• Controls :
• no concussion
• practicing a non-contact sport (athletics, rowing, badminton, capoeira, circus, running, crossfit, cycling, dancing, climbing, fencing, fitness, golf, gymnastics, bodybuilding, swimming, skating, Qi Gong, Taï chi, tennis, table tennis, shooting, trail running, volleyball, water polo) within a sports association
• age matched to patient (+/- 1 year)
• study level matched to patient (+/- 1 year)
• French or reading French without help

Exclusion Criteria:

• Patients :
• Legal protection measure
• Other neurological or psychiatric pathologies prior to concussion episodes
• Diagnosis of a neurodevelopmental disorder in childhood
• Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
• Addictive behaviors
• Current major depressive disorder or treated with antidepressants or benzodiazepines for less than 3 months
• Severe visual or motor problems that may interfere with the performance of the tests
• Controls :
• Legal protection measure
• History of proven concussion
• Other neurological or psychiatric pathologies
• Diagnosis of a neurodevelopmental disorder in childhood
• Score less than or equal to 5/19 on the "Matrix" subtest (intellectual retardation)
• Addictive behaviors
• Current major depressive episode or treated with antidepressants or benzodiazepines for less than 3 months
• Severe visual or motor problems that may interfere with the performance of the tests

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: Neuropsychological tests; The neuropsychological tests are computerized (TAP battery) or paper-and-pencil tests. They assess processing speed, short-term memory and auditory-verbal working memory capacity, episodic memory and selective attention.

Diagnostic test: Neuropsychological tests; List of neuropsychological tests: Matrix reasoning; D2-R; Coding; Symbol search; Digit span; Alertness (computerized TAP battery); Divided Attention (computerized TAP battery); Go / No go (computerized TAP battery); Incompatibility (computerized TAP battery); Working memory (computerized TAP battery); 16-item Free and Cued Recall or Stories subtest of the Children Memory Scale (CMS) for children only (< 17 years old); complex figure of the memory efficiency battery 144 or Word pairs of the Children Memory Scale for children only (< 17 years old)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Alertness time	Reaction time (ms) in the Alertness TAP test	At inclusion
Alertness error	Number of errors in the Alertness TAP test	At inclusion
Divided Attention time	Reaction time (ms) in the Divided Attention TAP test	At inclusion
Divided Attention error	Number of errors in the Divided Attention TAP test	At inclusion
Go/No-go time	Reaction time (ms) in the Go/No-go TAP test	At inclusion
Go/No-go error	Number of errors in the Go/No-go TAP test	At inclusion
Incompatibility time	Reaction time (ms) in the Incompatibility TAP test	At inclusion
Incompatibility error	Number of errors in the Incompatibility TAP test	At inclusion
Working Memory time	Reaction time (ms) in the Working Memory TAP test	At inclusion
Working Memory error	Number of errors in the Working Memory TAP test	At inclusion

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Matrix reasoning	Number of errors in Matrix reasoning test	At inclusion
Coding	Number of errors in coding test	At inclusion
Symbol	Number of errors symbol search test	At inclusion
Digit span	Number of errors in digit span test	At inclusion
16-item free and cued recall	Number of recall words in 16-item free and cued recall test	At inclusion
Complex figure	Score in the complex figure of the memory efficient battery 144. Score is determined by the number of elements of the figure recalled.	At inclusion
Stories	Number of errors in stories subtests of the Child Memory Scale (CMS)	At inclusion
Word pairs	Number of errors in word pairs subtests of the Child Memory Scale (CMS)	At inclusion
D2-R error	Number of errors in D2-R tests	At inclusion
D2-R time	Time (in seconds) to complete the D2-R test	At inclusion
Sociodemographic data	age and level of study of participants	At inclusion
Headaches	Presence or absence of headaches	At inclusion
Amnesia	Presence of anterograde or retrograde amnesia	At inclusion
SCAT	Symptom severity score on the Sport Concussion Assessment Tool (SCAT), range 0-132 (minimum-maximum), a higher score representing a more severe concussion	At inclusion
Sleep	Change in sleep (presence of hyper or insomnia)	At inclusion
Consciousness	Loss of initial consciousness or not	At inclusion
Position	Player position in the rugby team	At inclusion

Collaborators and Investigators

• Sponsor: University Hospital, Clermont-Ferrand
• Investigators: Principal Investigator: Tiphaine Vidal, University Hospital, Clermont-Ferrand

Study record dates

Study Major Dates

• Study Start (Actual): March 9, 2023
• Primary Completion (Estimated): March 9, 2027
• Study Completion (Estimated): March 9, 2027

Study Registration Dates

• First Submitted: January 17, 2023
• First Submitted That Met QC Criteria: January 30, 2023
• First Posted (Actual): February 9, 2023

Study Record Updates

• Last Update Posted (Actual): April 30, 2026
• Last Update Submitted That Met QC Criteria: April 27, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Injuries, Traumatic; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Wounds and Injuries; Craniocerebral Trauma; Trauma, Nervous System; Head Injuries, Closed; Wounds, Nonpenetrating; Brain Injuries; Brain Concussion
• Other Study ID Numbers: AOI 2021 VIDAL

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No